| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.68▲ | 1.69▲ | 1.70▲ | 1.72▼ | 1.74▼ |
| MA10 | 1.68▲ | 1.70▲ | 1.72▼ | 1.74▼ | 1.80▼ |
| MA20 | 1.69▲ | 1.73▼ | 1.72▼ | 1.72▼ | 1.75▼ |
| MA50 | 1.69▲ | 1.73▼ | 1.72▼ | 1.80▼ | 1.72▼ |
| MA100 | 1.72▼ | 1.73▼ | 1.72▼ | 1.73▼ | 1.89▼ |
| MA200 | 1.72▼ | 1.72▼ | 1.79▼ | 1.70▼ | 2.52▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.001▲ | -0.004▼ | -0.006▼ | 0.003▲ | -0.003▼ |
| RSI | 62.424▲ | 47.991▼ | 47.606▼ | 45.519▼ | 48.476▼ |
| STOCH | 32.143 | 23.377 | 10.441▼ | 44.056 | 34.852 |
| WILL %R | 0.000▲ | -65.217 | -68.000 | -50.000 | -72.727 |
| CCI | 82.117 | -47.945 | -79.545 | -7.447 | -27.091 |
|
Tuesday, April 14, 2026 06:00 AM
WILMINGTON, DE — Inhibikase Therapeutics Inc. (Nasdaq: IKT) has enrolled the first patient in its Phase 3 clinical trial evaluating IKT-001 for pulmonary arterial hypertension, advancing development ...
|
|
Wednesday, April 08, 2026 03:00 PM
WILMINGTON, DE — Inhibikase Therapeutics Inc. (Nasdaq: IKT) granted stock options to five newly hired non-executive employees covering a total of 685,718 shares under its 2026 Inducement Equity Plan.
|
|
Wednesday, April 08, 2026 12:27 AM
Detailed price information for Inhibikase Therapeutics Inc (IKT-Q) from The Globe and Mail including charting and trades.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 16/04/26 | 1.79 | 1.79 | 1.67 | 1.70 | 838,041 |
| 15/04/26 | 1.69 | 1.80 | 1.69 | 1.79 | 1,096,804 |
| 14/04/26 | 1.70 | 1.75 | 1.685 | 1.70 | 1,376,400 |
| 13/04/26 | 1.71 | 1.7686 | 1.68 | 1.71 | 813,945 |
| 10/04/26 | 1.69 | 1.74 | 1.665 | 1.70 | 863,311 |
| 09/04/26 | 1.74 | 1.765 | 1.67 | 1.69 | 1,113,028 |
| 08/04/26 | 1.83 | 1.83 | 1.72 | 1.74 | 701,431 |
| 07/04/26 | 1.79 | 1.80 | 1.69 | 1.76 | 729,157 |
| 06/04/26 | 1.80 | 1.83 | 1.745 | 1.79 | 692,789 |
| 02/04/26 | 1.74 | 1.83 | 1.73 | 1.80 | 759,859 |
|
|
||||
|
|
||||
|
|